In January 2023, I joined the group of Emile Voest as a PhD student. In my projects I aim to further improve personalized cancer treatment, by focusing on unconventional immunity in MSI tumors. To this end, I will make use of our patient derived organoid platform and establish co-cultures systems with different immune cell subsets.
